COMP <GO>
GEF vs TMO // RSI-14 & 200D SMA MOMENTUM
Greif Inc. (Class A) (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: GEF 4
— TMO 6
▲ RSI-14 & 200D SMA MOMENTUM LEADER: TMO
LAST: $82.19 (-0.31%) • MKT CAP: $3.79B
rsi-technicals
50.0
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
rsi-technicals
62.9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GEF VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GEF | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 22.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.90% | 9.30% | -5.40 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.1x | 30.4x | -5.30 | GEF | /valuation <GO> |
| Free Cash Flow Yield | 1.54% | 2.40% | -0.86 | TMO | /fcf-yield <GO> |
| Operating Margin | 4.30% | 17.40% | -13.10 | TMO | /operating-margins <GO> |
| Net Profit Margin | 21.40% | 15.10% | +6.30 | GEF | /net-margins <GO> |
| Revenue Growth (YoY) | — | 3.90% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.66% | 0.24% | +2.42 | GEF | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.50 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 50.0 | 62.9 | -12.89 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 4.2x | 36.3x | -32.10 | GEF | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.79B | $262.22B | -$258.42B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GEF REV | TMO REV | GEF GROSS % | TMO GROSS % | GEF FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.93B | $44.56B | 22.2% | — | $58.6M | $6.29B |
| FY 2024 | $4.35B | $42.88B | 20.6% | — | $356.0M | $7.27B |
| FY 2023 | $0 | $42.86B | — | — | $649.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GEF // BETA —
TMO // BETA 0.94